Shen Chia-Fang, Liu Szu-Yuan, Lee Chung-Hsin, Pan Szu-Yen, Shen Chiung-Chyi
Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung City 40705, Taiwan.
Int J Surg Case Rep. 2022 Sep;98:107553. doi: 10.1016/j.ijscr.2022.107553. Epub 2022 Aug 26.
Pituicytomas are low-grade glial tumors in the sellar and suprasellar region. They may be easily confused with pituitary lesions. We review the literature in order to better understand and categorize the natural history, clinical presentations, and treatments.
A 45-year-old female patient who complained of left eye blurred vision for 2 months. The imaging study revealed a solid sellar tumor with marked homogeneous enhancement following intravenous administration of gadolinium, and compression of the optic chiasm. Thus, under the preoperative diagnosis of pituitary macroadenoma, the patient underwent endoscope-assisted surgery via the transsphenoidal approach. The patient recovered well after surgery. The histopathological diagnosis was pituicytoma, WHO grade I.
Pituicytomas are defined as a circumscribed low-grade glial tumor arising from the neurohypophysis or infundibulum with bipolar spindle cells arranged in a fascicular or storiform pattern (a cartwheel). The clinical symptoms are variable depending on the tumor size and location. They usually present due to mass effect. The radiographic characteristics are not nonspecific. The diagnosis of pituicytoma is based on histopathological evidence. Pituicytomas consist of a solid proliferation of elongated spindle cells arranged in interlacing fascicles and/or in a "storiform" pattern. In immunohistochemical studies, pituicytomas was strongly expressed in TTF-1.
Pituicytomas are benign, slow-growing glial tumors. It is difficult to diagnosed before operation as its clinical presentations and imaging studies resemble those of non-functional pituitary adenomas. The best chance of successful treatment is gross total resection by the endoscopic approach or transcranial approach.
垂体细胞瘤是鞍区和鞍上区域的低度恶性胶质瘤。它们可能容易与垂体病变混淆。我们回顾文献以更好地了解并分类其自然史、临床表现和治疗方法。
一名45岁女性患者,主诉左眼视力模糊2个月。影像学检查显示鞍区实性肿瘤,静脉注射钆后有明显均匀强化,对视交叉有压迫。因此,在术前诊断为垂体大腺瘤的情况下,患者接受了经蝶窦入路的内镜辅助手术。术后患者恢复良好。组织病理学诊断为垂体细胞瘤,世界卫生组织I级。
垂体细胞瘤被定义为起源于神经垂体或漏斗的边界清楚的低度恶性胶质瘤,由双极梭形细胞以束状或车轮状排列(车轮状)。临床症状因肿瘤大小和位置而异。它们通常因占位效应而出现。影像学特征并非不具有特异性。垂体细胞瘤的诊断基于组织病理学证据。垂体细胞瘤由呈交织束状和/或“车轮状”排列的细长梭形细胞的实性增殖组成。在免疫组织化学研究中,垂体细胞瘤在甲状腺转录因子-1中强烈表达。
垂体细胞瘤是良性、生长缓慢的胶质瘤。由于其临床表现和影像学检查与无功能垂体腺瘤相似,术前难以诊断。成功治疗的最佳机会是通过内镜入路或经颅入路进行全切除。